Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 456

  • Showing results for kamm ma. Your search for kammma retrieved no results.
1.

Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures.

Schulberg JD, Wright EK, Holt BA, Sutherland TR, Hume SJ, Hamilton AL, Ross AL, Connell WC, Brown SJ, Lust M, Miller AM, Bell SJ, Kamm MA.

J Gastroenterol Hepatol. 2019 Oct 31. doi: 10.1111/jgh.14908. [Epub ahead of print]

PMID:
31674069
2.

Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE).

Ng SC, Kamm MA, Yeoh YK, Chan PKS, Zuo T, Tang W, Sood A, Andoh A, Ohmiya N, Zhou Y, Ooi CJ, Mahachai V, Wu CY, Zhang F, Sugano K, Chan FKL.

Gut. 2019 Oct 14. pii: gutjnl-2019-319407. doi: 10.1136/gutjnl-2019-319407. [Epub ahead of print]

3.

Defining Optimal Care for Functional Gut Disorders - Multi-Disciplinary Versus Standard Care: A Randomized Controlled Trial Protocol.

Basnayake C, Kamm MA, Salzberg M, Khera A, Liew D, Burrell K, Wilson-O'Brien A, Stanley A, Talley NJ, Thompson AJ.

Contemp Clin Trials. 2019 Sep;84:105828. doi: 10.1016/j.cct.2019.105828. Epub 2019 Aug 19.

PMID:
31437539
4.

Delivery of Care for Functional Gastrointestinal Disorders: A Systematic Review.

Basnayake C, Kamm MA, Salzberg MR, Wilson-O'Brien A, Stanley A, Thompson AJ.

J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14830. [Epub ahead of print]

PMID:
31411755
5.

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.

Julsgaard M, Hvas CL, Gearry RB, Gibson PR, Fallingborg J, Sparrow MP, Bibby BM, Connell WR, Brown SJ, Kamm MA, Lawrance IC, Vestergaard T, Svenningsen L, Baekdal M, Kammerlander H, Walsh A, Boysen T, Bampton P, Radford-Smith G, Kjeldsen J, Andrews JM, Subramaniam K, Moore GT, Jensen NM, Connor SJ, Wildt S, Wilson B, Ellard K, Christensen LA, Bell SJ.

Inflamm Bowel Dis. 2019 May 29. pii: izz110. doi: 10.1093/ibd/izz110. [Epub ahead of print]

PMID:
31141607
6.

Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation.

Lai CY, Sung J, Cheng F, Tang W, Wong SH, Chan PKS, Kamm MA, Sung JJY, Kaplan G, Chan FKL, Ng SC.

Aliment Pharmacol Ther. 2019 Feb;49(4):354-363. doi: 10.1111/apt.15116. Epub 2019 Jan 9. Review.

PMID:
30628108
7.

Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.

Paramsothy S, Nielsen S, Kamm MA, Deshpande NP, Faith JJ, Clemente JC, Paramsothy R, Walsh AJ, van den Bogaerde J, Samuel D, Leong RWL, Connor S, Ng W, Lin E, Borody TJ, Wilkins MR, Colombel JF, Mitchell HM, Kaakoush NO.

Gastroenterology. 2019 Apr;156(5):1440-1454.e2. doi: 10.1053/j.gastro.2018.12.001. Epub 2018 Dec 6.

PMID:
30529583
8.

Editorial: treating strictures in inflammatory bowel disease.

Kamm MA.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1312-1313. doi: 10.1111/apt.14987. No abstract available.

PMID:
30488631
9.

Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease.

Khera AJ, Chase JW, Salzberg M, Thompson AJV, Kamm MA.

Inflamm Bowel Dis. 2019 Feb 21;25(3):620-626. doi: 10.1093/ibd/izy344.

PMID:
30452638
10.

Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific.

Ng SC, Kaplan GG, Tang W, Banerjee R, Adigopula B, Underwood FE, Tanyingoh D, Wei SC, Lin WC, Lin HH, Li J, Bell S, Niewiadomski O, Kamm MA, Zeng Z, Chen M, Hu P, Ong D, Ooi CJ, Ling KL, Miao Y, Miao J, Janaka de Silva H, Niriella M, Aniwan S, Limsrivilai J, Pisespongsa P, Wu K, Yang H, Ng KK, Yu HH, Wang Y, Ouyang Q, Abdullah M, Simadibrata M, Gunawan J, Hilmi I, Lee Goh K, Cao Q, Sheng H, Ong-Go A, Chong VH, Ching JYL, Wu JCY, Chan FKL, Sung JJY.

Am J Gastroenterol. 2019 Jan;114(1):107-115. doi: 10.1038/s41395-018-0233-2.

PMID:
30177785
11.

Outcome of hospital outpatient treatment of functional gastrointestinal disorders.

Basnayake C, Kamm MA, Salzberg M, Stanley A, Khera A, Burrell K, Wilson-O'Brien A, Hebbard G, Thompson AJ.

Intern Med J. 2019 Feb;49(2):225-231. doi: 10.1111/imj.14067.

PMID:
30091176
12.

Proteus spp. as Putative Gastrointestinal Pathogens.

Hamilton AL, Kamm MA, Ng SC, Morrison M.

Clin Microbiol Rev. 2018 Jun 13;31(3). pii: e00085-17. doi: 10.1128/CMR.00085-17. Print 2018 Jul. Review.

13.

Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.

Ravenscroft G, Pannell S, O'Grady G, Ong R, Ee HC, Faiz F, Marns L, Goel H, Kumarasinghe P, Sollis E, Sivadorai P, Wilson M, Magoffin A, Nightingale S, Freckmann ML, Kirk EP, Sachdev R, Lemberg DA, Delatycki MB, Kamm MA, Basnayake C, Lamont PJ, Amor DJ, Jones K, Schilperoort J, Davis MR, Laing NG.

Neurogastroenterol Motil. 2018 Sep;30(9):e13371. doi: 10.1111/nmo.13371. Epub 2018 May 21.

PMID:
29781137
14.

Urbanization and the gut microbiota in health and inflammatory bowel disease.

Zuo T, Kamm MA, Colombel JF, Ng SC.

Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):440-452. doi: 10.1038/s41575-018-0003-z. Review.

PMID:
29670252
15.

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.

Danese S, Bonovas S, Lopez A, Fiorino G, Sandborn WJ, Rubin DT, Kamm MA, Colombel JF, Sands BE, Vermeire S, Panes J, Rogler G, D'Haens G, Peyrin-Biroulet L.

Gastroenterology. 2018 Jul;155(1):76-87. doi: 10.1053/j.gastro.2018.03.032. Epub 2018 Mar 28. Review.

PMID:
29601825
16.

Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease.

Wright EK, Kamm MA, De Cruz P, Hamilton AL, Selvaraj F, Princen F, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Gearry RB, Selby W, Bell SJ, Brown SJ, Connell WR.

J Crohns Colitis. 2018 May 25;12(6):653-661. doi: 10.1093/ecco-jcc/jjy003.

PMID:
29385469
17.

Rapid changes in epidemiology of inflammatory bowel disease.

Kamm MA.

Lancet. 2018 Dec 23;390(10114):2741-2742. doi: 10.1016/S0140-6736(17)32669-7. Epub 2017 Oct 16. No abstract available.

PMID:
29050647
18.

Editorial: visceral fat as a predictor of post-operative recurrence of Crohn's disease-Authors' reply.

Holt DQ, Moore GT, Strauss BJG, Hamilton AL, De Cruz P, Kamm MA.

Aliment Pharmacol Ther. 2017 Jun;45(12):1552-1553. doi: 10.1111/apt.14102. No abstract available.

19.

Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Paramsothy S, Paramsothy R, Rubin DT, Kamm MA, Kaakoush NO, Mitchell HM, Castaño-Rodríguez N.

J Crohns Colitis. 2017 Oct 1;11(10):1180-1199. doi: 10.1093/ecco-jcc/jjx063. Review.

PMID:
28486648
20.

Long-term outcome of sacral neuromodulation for chronic refractory constipation.

Maeda Y, Kamm MA, Vaizey CJ, Matzel KE, Johansson C, Rosen H, Baeten CG, Laurberg S.

Tech Coloproctol. 2017 Apr;21(4):277-286. doi: 10.1007/s10151-017-1613-0. Epub 2017 Apr 20.

Supplemental Content

Support Center